MAPK inhibitor shows promise in clinical trial for neuropathic pain

被引：11

|

作者：

Katie Kingwell

机构：

来源：

Nature Reviews Neurology | 2011年 / 7卷 / 7期

关键词：

D O I：

10.1038/nrneurol.2011.84

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：360 / 360

相关论文

共 50 条

[1] Cell transplantation shows promise in alleviating neuropathic pain
不详
FUTURE NEUROLOGY, 2012, 7 (04) : 377 - 378
[2] Selective p38α MAPK inhibitor shows promise
Jessica McHugh
Nature Reviews Rheumatology, 2018, 14 : 321 - 321
[3] Selective p38α MAPK inhibitor shows promise
McHugh, Jessica
NATURE REVIEWS RHEUMATOLOGY, 2018, 14 (06) : 321 - 321
[4] Clinical trial of magnesium in neuropathic pain
Pickering, G.
Picard, P.
Dubray, C.
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2009, 23 : 110 - 110
[5] PARP inhibitor shows promise in inherited ovarian cancer trial
不详
EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (06) : 792 - 792
[6] The validity of the neuropathic pain scale for assessing diabetic neuropathic pain in a clinical trial
Jensen, MP
Friedman, M
Bonzo, D
Richards, P
CLINICAL JOURNAL OF PAIN, 2006, 22 (01): : 97 - 103
[7] Investigational genital herpes vaccine shows promise in clinical trial
Yianni, Mary
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2012, 10 (02) : 117 - 117
[8] AIDS DRUG SHOWS PROMISE IN PRELIMINARY CLINICAL-TRIAL
MARX, JL
SCIENCE, 1986, 231 (4745) : 1504 - 1505
[9] Investigational genital herpes vaccine shows promise in clinical trial
Yianni, Mary
IMMUNOTHERAPY, 2012, 4 (02) : 139 - 139
[10] Investigational genital herpes vaccine shows promise in clinical trial
Yianni, Mary
FUTURE VIROLOGY, 2012, 7 (02) : 121 - 121

← 1 2 3 4 5 →